Economic and Diagnostic Biomarker Tests of Neonatal Sepsis: A Prospective Study from a Tertiary Care Hospital in a Low-Income Country

Khadka, Priyatam; Maharjan, Govinda; Chapagain, Ganesh; JanukaThapaliya, undefined; Paudyal, Prakash

doi:https://doi.org/10.1155/2022/5166380

BioMed Research International

On this page

Abstract Background Methods Results Discussion Limitations Conclusion Abbreviations Data Availability Ethical Approval Consent Conflicts of Interest Authors’ Contributions Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 5166380 | https://doi.org/10.1155/2022/5166380

Economic and Diagnostic Biomarker Tests of Neonatal Sepsis: A Prospective Study from a Tertiary Care Hospital in a Low-Income Country

Priyatam Khadka,¹Govinda Maharjan,¹Ganesh Chapagain,¹ JanukaThapaliya,¹and Prakash Paudyal²

Academic Editor: Surendiran B.

Received01 Jul 2022

Revised31 Oct 2022

Accepted03 Nov 2022

Published25 Nov 2022

Abstract

Background. Neonatal sepsis is a leading cause of morbidity and mortality in low-and middle-income countries (LMICs). There are several sophisticated biomarkers; however, they are still insufficient in precision. In this perspective, our study aims to search for a pragmatic diagnostic biomarker in the age category. Methods. A cross-sectional study was conducted over six months(April-September 2018). All neonates with a diagnosis of probable sepsis were included. Logistic regression analysis of demographic variables was done to elucidate any association with confirmed sepsis cases. The median with interquartile range (IQR)] and mean with standard deviation (SD) were calculated, and then compared. The area under the receiver operating characteristic curve (AUROC) of the commonly opted biomarker tests [distribution width of red blood cells (RDW) and platelets(PDW), mean platelet volume(MPV), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR)] was compared to the culture-confirmed case. Results. Of the 171 suspected sepsis subjects, we discovered a significant burden of newborn sepsis, with 18.7% of cases being culture-confirmed. 66 Early-onset sepsis(EOS) and 105 Late-onset sepsis(LOS) probable sepsis cases were enrolled. A higher incidence was revealed among male infants 24(14%) compared to females 8(4.7%). On logistic regression analysis, preterm birth [odds ratio (OR): 10.9, 95% confidence interval (CI): 4.5-26.9] and low birth weight (OR: 6.5, 95% CI: 2.4-17.9) were significantly associated. Coagulase-negative Staphylococcus aureus (CoNS) (n =6) among gram-positive, and Pseudomonas aeruginosa (n =6) was among gram-negative, were the leading etiologies. Escherichia coli (n =3) was the predominant bacteria in EOS subjects, while Pseudomonas aeruginosa (n =6) among LOS. Median interquartile range(IQR): platelet count 144.5(99-192), red cell distribution width 18(16.9-20), CRP 6(3-18.3); and mean ± SD: MPV (11.7 ± 1.7); PDW (15.2 ± 3.5) were attained, among confirmed cases. The AUROC, of biomarker tests was attained in the order: PDW(0.86) > MPV(0.81) > RDW(0.76) > CRP(0.67) > ESR(0.59); similarly, the cut-off order was >11.2, >10.4, >16.8, >2.9, >4.5, respectively. Conclusions. Our finding shows an increment in the width and volume of RBCand platelet: RDW, MPV, and PDW have a diagnostic role in neonatal sepsis.

1. Background

Sepsis is a leading cause of morbidity and mortality in neonates, accounting for one-third of all neonatal deaths worldwide [1]. However, the incidence and case fatality are distributed unevenly. The incidence of sepsis in high-income countries (HICs) ranges from 1 to 5 cases/1000 live births; however, it is estimated to be at least 3 to 20-fold higher in low- and middle-income countries (LMICs) [2–4]. Similarly, the case fatality rate in LMICs can reach up to 65%, while it is less than 2% in HICs [5, 6]. Mounting shreds of evidence have shown that the irony of neonatal sepsis is directly linked with existing healthcare facilities and the accessibility of early diagnostic modalities [3]. Probably, that could be the cause of the aforementioned discrepancies. Neonatal infection is one of the leading causes of hospital admissions and neonatal deaths in Nepal—the prevalence of the infection ranges between 2 and 4% [7]. In 2015, 12,881 neonatal deaths were reported in Nepal, of which 18.4% were attributed to sepsis [6]. The data could be even worse since numerous undocumented neonatal deaths are yet to be enrolled in Nepal’s National Database due to deficient recording, reporting, and data analyzing modalities.

For early diagnosis, a myriad of sophisticated biomarker tests are available; however, they are still insufficient in terms of precision and accessibility. Turning to LMICs, the cost efficiency and accessibility of diagnostic tests are another paramount concern. Therefore, cost-efficient, reliable, and early predictors/biomarkers of neonatal sepsis are being searched for worldwide. With this backdrop, our study aims to search for pragmatic biomarker tests for neonatal sepsis.

2. Methods

2.1. Design of the Study and the Population Sample

A cross-sectional study was conducted at Nepal National Hospital (NNH), a multi-speciality tertiary care hospital in Nepal, for 6 months (April-September 2018). All neonates admitted to the NICU and PICU with a presumptive clinical diagnosis of sepsis were enrolled. A pre-tested questionnaire was administered to each suspected neonate and their parents were approached for consent to take part in the study (Supplementary Material 1). Data regarding personal information (patient’s demographics, including residence locality) and existing infectious diseases were coded and kept confidential.

2.2. Inclusion and Exclusion Criteria

All clinically suspected and consented neonates admitted to NNH during our study period were included in the study. However, neonates presenting with major congenital abnormalities and those previously treated as sepsis cases were excluded from the study. The categorization of congenital abnormalities in our study was based on the European Surveillance of Congenital Anomalies (EUROCAT) guidelines [8].

2.3. Diagnosis of Sepsis

The clinical investigation/suspicion of sepsis was made by a unit pediatrician relying upon the clinical history, likely occurring clinical signs, and/or underlying risk factors. As per the NICU protocol followed by Nepal National Hospital, sepsis was defined as culture-positive sepsis(confirmed sepsis) if the blood culture was positive in a patient with clinical signs of sepsis. However, a negative blood culture with existing clinical signs was assessed as culture-negative sepsis (probable sepsis). In reference to WHO classification, we considered babies born alive before 37 weeks of pregnancy as preterm neonates. However, further characterization of extremely preterm(less than 28 weeks), very preterm (28 to 32 weeks), and moderate to late preterm(32 to 37 weeks) was not done in our study. Likewise, babies born alive after the completion of 37 weeks of pregnancy were defined as full-term neonates.

2.4. Microbiological Investigation

Neonatal sepsis could be caused by one or more systemic infections such as septicemia, urinary tract infections, pneumonia, meningitis, arthritis, or osteomyelitis; nevertheless, neonates with positive blood culture results were considered confirmed sepsis cases [9].

1-2 ml of peripheral blood samples were drawn from all neonates, those having a presumptive diagnosis of sepsis. Aseptically, the samples were injected into BD-BACTEC Peds Plus/F culture vials (Becton Dickinson, UK) and incubated in an automated BD BACTEC FX40 (Becton Dickinson, UK) culture system. Upon an indication of culture-positive, a small drop (approximately a loopful volume) of blood was aspirated and inoculated on 5% sheep blood agar, MacConkey agar, and chocolate agar. Further, isolation and identification of the isolates were done by standard microbiological techniques—biotyping (colony morphology, staining reaction, and biochemical characteristics) and serotyping using specific antisera(Denka Seiken Co. Ltd., Tokyo, Japan). The antimicrobial susceptibility testing (AST) was performed by the disk diffusion method [modified Kirby-Bauer method] on Mueller Hinton agar (Hi-Media, India) in compliance with standard procedures recommended by the Clinical and Laboratory Standards Institute (CLSI), Wayne, PA, USA [10].

2.5. Serological and Hematological Indicators of Sepsis

Quantitative serum CRP level was measured by an automatic clinical chemistry analyzer –XL 200 ERBA Diagnostic Mannheim. The Sysmex (XS-500i) automated hematology system analyzer was used to measure complete blood cell (CBC) parameters (Total leukocytes count, Hemoglobin, Hematocrit, Platelet count, Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), Plateletcrit (PCT), Red Blood Cell (RBC), Mean Corpuscular Volume (MCV), Mean Corpuscular Haemoglobin (MCH), Mean Corpuscular Haemoglobin Concentration(MCHC). ESR(erythrocyte sedimentation rate) was determined with standardized methods of miro-ESR. Blood was collected in a pre-heparinized 75 mm long micro-hematocrit tube (Fisher brandTM micro-hematocrit Capillary Tubes) with an internal diameter of 1.1 mm and an external diameter of 1.5 mm and allowed to stand vertically for an hour. After 1 hour, a fall in the column of blood in the capillary tube was measured.

2.6. Data Analysis

Statistical analysis was conducted in SPSS (version 20.0). All qualitative variables were expressed in absolute frequency(N) with percentage(%), while quantitative variables were calculated as mean ± standard deviation (SD) or median with interquartile range(IQR). Logistic regression analysis of demographic variables was done to elucidate any association with confirmed sepsis cases; an odds ratio with 95% confidence interval(CI) was calculated. Receiver Operating Characteristics (ROC) curve analysis was done to evaluate the utility and area under ROC curve (AUROC) was compared. P value≤0.05 was considered a significant threshold in these statistical evaluations.

3. Results

3.1. Patients’ Demographic Features

In this cross-sectional investigation, we discovered a high burden of newborn sepsis, with 18.7% of 171 suspected sepsis individuals having the condition. The confirmed sepsis rate was higher in males 24(14%) compared to females 8(4.7%). LOS occurred in 23 (13.5%) of the culture-positive sepsis events. Among demographic variables, preterm delivery and low birth weight were significantly associated with sepsis. On logistic regression analysis, preterm birth [odds ratio (OR): 10.9, 95% confidence interval (CI): 4.5-26.9] and low birth-weight (OR: 6.5, 95% CI: 2.4-17.9) were assessed (Table 1).

3.2. Microbiological Findings: Distribution of Sepsis-Causing Isolates

Coagulase-negative Staphylococcus aureus(CoNS) (n =6) among gram-positive bacteria(GPB), and Pseudomonas aeruginosa (n =6) among gram-negative bacteria(GNB), were the leading etiologies in our study. Escherichia coli (n =3) was the predominant bacteria in EOS subjects, while Pseudomonas aeruginosa (n =6) among LOS (Table 2).

3.3. Laboratory Findings: Biomarker Tests and their Comparisons in Neonatal Sepsis

Among culture-confirmed cases, Median IQR: platelet count 144.5(99-192), red cell distribution width 18(16.9-20), CRP 6(3-18.3); and mean ± SD: MPV (11.7 ± 1.7); PDW (15.2 ± 3.5) were attained (Table 3). ROC curve was used to compare the test efficacy of implicated diagnostic parameters to sepsis, viz. PDW, MPV, CRP, RDW-CV, and ESR (Figure 1). The AUROC of biomarker tests was attained in the order: PDW(0.86) > MPV(0.81) > RDW(0.76) > CRP(0.67) > ESR(0.59); similarly, the cut-off order was >11.2, >10.4, >16.8, >2.9, >4.5, respectively (Table 4).

4. Discussion

In this cross-sectional study, we found a high burden of neonatal sepsis: of 171 probable sepsis subjects, 32(18.7%) were found to be culture-confirmed sepsis. Neonates with preterm delivery and low birth weight are the demographic variables significantly associated with sepsis. Sepsis in preterm infants remains a significant clinical problem which is further complicated by disease heterogeneity and the absence of rapid and reliable diagnostic tests [11, 12]. Our study tries to address these diagnostic complexities. Relying on the gold standard diagnostic culture, this study demonstrated 9.9% of the preterm neonates had suffered from sepsis. The finding is nearly half of the corresponding findings of Jain et al. 20-40% [13] and Salma et al. 21.5% [11]. The deficient immune system, compromised innate immune system, and an increased need to support invasive devices are commonly cited risk factors for sepsis among preterm neonates [12].

Geographical variations have been observed in the incidence of neonatal sepsis. In South Asia, the variable prevalence of culture-positive sepsis was reported to be from 6 to 57% [4, 14–17]. Although this study’s rate of culture-proven sepsis (18.7%) is less than half that of the surrounding studies’ reported 35.5% rate [18]. Furthermore, similar studies conducted in other developing countries from Africa and Asia have reported: Ethiopia(44.7%), Uganda(37%), Nigeria(45.9%), Ghana(17%), Tanzania(47.1%), Bangladesh(34.9%) and India(25 to 45%) [5, 19–24]. This is attributed to changing patterns of antibiotic use and lifestyles [25]. On a specific note, culture-negative does not preclude sepsis because nearly 26% of neonatal sepsis could be due to anaerobic organisms. Additionally, viruses(rubella, cytomegalovirus), protozoans (Toxoplasma gondii), and treponema (treponema pallidum) have also shown their possible implications [25, 26]. Therefore, a diagnosis of consideration is required.

The epidemiology of neonatal sepsis has been found to change with time. Since 1990, EOS has decreased significantly; however, the LOS has remained unchanged [27, 28]. In our study, the proportion of LOS was higher than EOS (LOS13.5% vs. EOS 5.3%), similar to the aforementioned studies [18, 23, 29]. Of culture-proven sepsis, nearly 72% of episodes are late-onset types, suggesting the horizontal transfer of infection in our study; the finding is comparable to the other Asian countries [30, 31]. However, in other Asian countries such as Pakistan and Bangladesh, the rate of vertical transmission, i.e. the early-onset type was found to be higher [15, 32]. Poor hygienic procedures during delivery were believed to be the reason behind this upset.

The individualized isolates contributing to sepsis could be different due to diverse patients’ residences, hygienic practices, and hospital settings/protocols implicated in infection control. In this study, GNB was the leading cause of both early and late-onset sepsis, which corresponds to elucidations by several research institutes of LMICs [4, 33, 34]. The predominant isolates contributing to sepsis were Pseudomonas aeruginosa followed by Escherichia coli in our study; nevertheless, the nearby hospital reported Klebsiella pneumonia as the commonest cause of sepsis [4, 18, 35, 36]. Turning to GPB, CoNS followed by Staphylococcus aureus was the commonest pathogen behind neonatal sepsis in our study; the finding is similar to that reported by Manandhar et al. [4] and Sahet. al [18], .from the neighboring hospitals. Nonetheless, the bacterial predominance was found to be reversed in another similar study [36].

The comparison of commonly employed, accessible, and cost-effective biomarker tests against neonatal sepsis is crucial—particularly for those people who reside in low-income countries. The illustrative findings could assist in policymaking and designing strategic outlines. With this rationale, we conducted this study. Complete blood cells, including RDW and PDW, CRP, and ESR were compared to the gold standard bacterial culture.

The usefulness of CBC as a biomarker of neonatal sepsis has not yet been proven due to poor positive and negative predictive values; however, the importance of a normal CBC value in ruling out sepsis should not be underestimated [37–42]. Several studies have shown that total leukocyte count, platelet count, absolute neutrophil count, red cell indices, and the immature-to-total neutrophil ratio correlate with neonatal sepsis [37, 41–43]. In our study, platelet count, MPV, and MCH have shown a significant association with neonatal sepsis. These findings are consistent with some relevant kinds of literature [44–49].

Sepsis has been shown in clinical and experimental studies to have a wide range of effects on erythrocytes—altering the heterogeneity of RDW, though its diagnostic implications are still being debated [50]. Therefore, we tried to explore the diagnostic application of RDW in our study. In our study population, RDW was significantly higher in confirmed sepsis cases with a median IQR =18(16.9-20) with a P-value:<0.001. The finding is in line, as reported by Hu et al., who reported 18.9-19.9% as the diagnostic threshold for neonatal sepsis [51]. Similar other studies support our hypothesis on the diagnostic values of RDW in neonatal sepsis [52–56].

Several diagnostic models have supported PDW as an early and economic biomarker of sepsis. While testing the applicability of PDW in sepsis diagnosis, we observed PDW in culture-confirmed sepsis was 15.2 ± 3.5 while in probable sepsis it was 10.5 ± 3.09. The illustration is in line with the findings of Ahmad et al. as he reported a median PDW 12.3 in confirmed sepsis cases [57]. Majumdar et al. and Patrick et al. reported increased PDW by >19.1% among neonates has the diagnostic value, however [58, 59].

Platelet indices (platelet count, MPV, PCT, and immature platelet fraction) are acute phase reactants and these parameters could vary with inflammation and increased platelet consumption/production [60]. Pieces of evidence have shown that platelet indices could be both predictive as well as prognostic biomarkers in neonatal sepsis [60, 61]. In the present study, we compared the platelet indices (platelet count, MPV, and PCT) as predictive biomarkers in neonatal sepsis cases. In confirmed sepsis cases, Median (IQR) platelet count: 144.5(99-192); mean ± SD, MPV: 11.7 ± 1.7; mean ± SD, PCT%: 0.20 ± 1.15 were observed. Of them, platelet count and MPV were statistically significant. Our findings are well-supported by the conclusions of Majumdar et al. [58], Mishra S et al. [60], and Dundar B et al. [61].

C-reactive protein, an infectious inflammatory biomarker, may complement the evaluation of clinical signs and risk factors within the diagnosis of sepsis—several studies have shown its applicability in precocious diagnosis as the test is easily available [62–64]. We found the median serum CRP was significantly higher in confirmed sepsis cases compared to probable sepsis, being 6 mg/L(IQR =3-18.3) in confirmed sepsis and 2.7 mg/L (IQR =2.1-7.7) in probable sepsis cases. The assertion of Tosson et al. is in line with our findings [65]. Earlier, in a study from Nepal, Shah et al. illustrated the sensitivity (44%) and specificity (92%) of CRP among sepsis proven-cases which supports its validity as a biomarker test [66]. However, diagnosis of consideration is required: the spurious increase in the level of CRP in numerous conditions such as meconium aspiration syndrome, delayed transition after birth, premature infant exposure to glucocorticoids, prolonged rupture of membranes, stressful delivery or fetal distress, prolonged labor, maternal fever during labor, perinatal asphyxia or shock, surfactant administration, intra-ventricular hemorrhage, and pneumothorax, may mislead the diagnosis [37, 64, 67].

Micro-erythrocyte sedimentation rate is single, cheap, easy to perform, and less time-consuming with a sensitivity of 63.3% and 60%, respectively [68]. In a resource-limited setting, as a supportive biomarker, ESR is often used as a diagnostic tool. Therefore, we added the test to our study. In our study, the median micro-ESR was 6.5(IQR =3-14); although the statistical association was not found as an alternative in diagnosis and in monitoring therapeutic progress [69, 70]. Similar studies done in Nepal and India have shown the significance of micro-ESR levels concerning confirmed sepsis: Manandhar et al. from Nepal found 17.3% of culture-confirmed sepsis had elevated ESR by 33.3%, while Ghaliyaz et al. from India found 32% of culture-confirmed sepsis had elevated ESR by 38% [70, 71].

These economical and commonly accessible biomarker tests were compared with ROC curve analysis. The AUROC of the biomarker test was attained in the order: PDW(0.86) > MPV(0.81) > RDW(0.76) > CRP(0.67) > ESR(0.59); similarly, the cut-off order was >11.2, >10.4, >16.8, >2.9, >4.5, respectively. The diagnostic applicability of these biomarker tests in neonatal sepsis has not been compared before.

5. Limitations

The broad range of other biomarker tests could not be compared because of deficient funding and starved laboratory settings—only tests available in our setting were compared.

6. Conclusion

Particularly in LMICs, the comparison of accessible and cost-effective biomarker tests in the diagnosis of neonatal sepsis is crucial since healthcare facilities are not approachable to everyone. Our study revealed that the increment in the width and volume of RBC and platelets has a promising role in the diagnosis of neonatal sepsis. Therefore, these could assist in policy making and designing diagnostic outlines for neonatal sepsis. Validation with larger prospective studies on these biomarker tests is required, however.

Abbreviations

AUROC:	Area under receiver operating characteristics
CBC:	Complete blood cell
CRP:	C-reactive protein
EOS:	Early-onset sepsis
ESR:	Erythrocyte sedimentation rate
GNB:	Gram-negative bacteria
GPB:	Gram-positive bacteria
LOS:	Late-onset sepsis
LMICs:	Low-and middle-income countries
PCT:	Plateletcrit
ROC:	Receiver operating characteristics.

Data Availability

The data generated or analyzed during this study are included in this published article, and the remainder is available upon reasonable request from the corresponding author.

Ethical Approval

Ethical approval was taken from Nepal Health Research Council(NHRC); Ref. No.: 3050 before the study was undertaken. As stated by the declaration of Helsinki and following Good Clinical and Laboratory Practices, all methods were devised and performed. Written informed consent was taken from all parents before participating in the study. Data regarding personal information and infectious disease was coded and kept confidential.

Not applicable.

Conflicts of Interest

The authors declare that they have no competing interests.

Authors’ Contributions

PK made the diagnosis, designed the manuscript, reviewed the literature, and prepared the article for submission. GM, PP, JT and GC helped with literature reviews, gave a research paper concept, and critically reviewed the manuscript. All authors read and approved the final manuscript.

Funding

Not applicable (Nil).

Acknowledgments

We are profoundly obliged to all the patients participating in this study. Our special thanks go to all the laboratory staff, management, and officials of Nepal National Hospital, Kathmandu for providing the opportunity to carry out this research work.

Supplementary Materials

Supplementary Material. Questionaire for demographic features. (Supplementary Materials)

References

C. Fleischmann, F. Reichert, A. Cassini et al., “Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis,” Archives of Disease in Childhood, vol. 106, no. 8, pp. 745–752, 2021.
View at: Publisher Site | Google Scholar
A. K. M. Zaidi, W. C. Huskins, D. Thaver, Z. A. Bhutta, Z. Abbas, and D. A. Goldmann, “Hospital-acquired neonatal infections in developing countries,” The Lancet, vol. 365, no. 9465, pp. 1175–1188, 2005.
View at: Publisher Site | Google Scholar
United Nations, Interagency Group for Child Mortality Estimation. Levels & Trends in Child Mortality: Report 2010: Estimates Developed by the UN Inter-Agency Group for Child Mortality Estimation, UNICEF, New York, 2019, https://reliefweb.int/sites/reliefweb.int/files/resources/UN-IGME-Child-Mortality-Report-2019.pdf.
S. Manandhar, P. Amatya, I. Ansari et al., “Risk factors for the development of neonatal sepsis in a neonatal intensive care unit of a tertiary care hospital of Nepal,” BMC Infectious Diseases, vol. 21, no. 1, p. 546, 2021.
View at: Publisher Site | Google Scholar
S. Murthy, M. A. Godinho, V. Guddattu, L. E. S. Lewis, and N. S. Nair, “Risk factors of neonatal sepsis in India: A systematic review and meta-analysis,” PLoS One, vol. 14, no. 4, article e0215683, 2019.
View at: Publisher Site | Google Scholar
United Nations Children’s Fund, Maternal and Newborn Health Disparities, UNICEF, Nepal, New York, 2018, https://data.unicef.org/resources/maternal-newborn-health-disparities-country-profiles/Nepal.
S. S. Budhathoki, A. K. Sunny, P. G. Paudel et al., “Epidemiology of neonatal infections in hospitals of Nepal: evidence from a large- scale study,” Archives of Public Health, vol. 78, no. 1, p. 39, 2020.
View at: Publisher Site | Google Scholar
“EUROCAT,” 2018, http://www.eurocat-network.eu/aboutus/datacollection/guidelinesforregistration/malformationcodingguides.
View at: Google Scholar
C. Lahariya, C. R. Sudfeld, D. Lahariya, and S. S. Tomar, “Causes of child deaths in India, 1985-2008: a systematic review of literature,” Indian Journal of Pediatrics, vol. 77, no. 11, pp. 1303–1311, 2010.
View at: Publisher Site | Google Scholar
CLSI, “Performance standards for antimicrobial susceptibility testing. CLSI supplement M100S,” Clinical and Laboratory standards Institute, Clinical and Laboratory standards Institute, Wayne, PA, USA, 26th edition, 2016.
View at: Google Scholar
K. Salama, A. Gad, and S. El Tatawy, “Sepsis profile and outcome of preterm neonates admitted to neonatal intensive care unit of Cairo University Hospital,” Egyptian Pediatric Association Gazette, vol. 69, no. 1, 2021.
View at: Publisher Site | Google Scholar
A. Collins, J.-H. Weitkamp, and J. L. Wynn, “Why are preterm newborns at increased risk of infection?” Archives of Disease in Childhood. Fetal and Neonatal Edition, vol. 103, no. 4, pp. F391–F394, 2018.
View at: Publisher Site | Google Scholar
K. Jain, M. J. Sankar, S. Nangia et al., “Causes of death in preterm neonates (<33 weeks) born in tertiary care hospitals in India: analysis of three large prospective multicentric cohorts,” Journal of Perinatology, vol. 39, no. S1, pp. 13–19, 2019.
View at: Publisher Site | Google Scholar
Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration, “Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study,” The Lancet Global Health, vol. 4, no. 10, pp. e752–e760, 2016.
View at: Publisher Site | Google Scholar
O. Ullah, A. Khan, A. I. Ambreen, T. Akhtar, A. J. Gandapor, and A. M. Khan, “Antibiotic sensitivity pattern of bacterial isolates of neonatal septicemia in Peshawar, Pakistan,” Archives of Iranian Medicine, vol. 19, no. 12, 2016.
View at: Google Scholar
F. Monjur, F. Rizwan, M. Asaduzzaman et al., “Antibiotic sensitivity pattern of causative organisms of neonatal septicemia in an urban hospital of Bangladesh,” Indian Journal of Medical Sciences, vol. 64, no. 6, pp. 265–271, 2010.
View at: Publisher Site | Google Scholar
S. Ansari, H. P. Nepal, R. Gautam, S. Shrestha, P. Neopane, and M. L. Chapagain, “Neonatal septicemia in Nepal: early-onset versus late-onset,” International journal of pediatrics, vol. 2015, Article ID 379806, 6 pages, 2015.
View at: Publisher Site | Google Scholar
R. Sah, S. Bhattarai, S. Basnet et al., “A Prospective Study on Neonatal Sepsis in a Tertiary Hospital, Nepal,” Journal of Pure and Applied Microbiology, vol. 15, no. 4, pp. 2409–2419, 2021.
View at: Publisher Site | Google Scholar
A. S. M. N. U. Ahmed, M. A. K. A. Chowdhury, M. Hoque, and G. L. Darmstadt, “Clinical and bacteriological profile of neonatal septicemia in a tertiary level pediatric hospital in Bangladesh,” Indian Pediatrics, vol. 39, no. 11, pp. 1034–1039, 2002.
View at: Google Scholar
J. Mugalu, M. K. Nakakeeto, S. Kiguli, and D. H. Kaddu-Mulindwa, “Aetiology, risk factors and immediate outcome of bacteriologically confirmed neonatal septicaemia in Mulago hospital, Uganda,” African Health Sciences, vol. 6, no. 2, pp. 120–126, 2006.
View at: Google Scholar
T. G/eyesus, F. Moges, S. Eshetie, B. Yeshitela, and E. Abate, “Bacterial etiologic agents causing neonatal sepsis and associated risk factors in Gondar, Northwest Ethiopia,” BMC Pediatrics, vol. 17, no. 1, p. 137, 2017.
View at: Publisher Site | Google Scholar
F. Y. Aku, P. Akweongo, K. M. Nyarko et al., “Factors associated with culture proven neonatal sepsis in the ho municipality 2016,” The Pan African Medical Journal, vol. 36, p. 281, 2020.
View at: Google Scholar
N. Kayange, E. Kamugisha, D. L. Mwizamholya, S. Jeremiah, and S. E. Mshana, “Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania,” BMC Pediatrics, vol. 10, no. 1, p. 39, 2010.
View at: Publisher Site | Google Scholar
M. M. Meremikwu, C. E. Nwachukwu, A. E. Asuquo, J. U. Okebe, and S. J. Utsalo, “Bacterial isolates from blood cultures of children with suspected septicaemia in Calabar, Nigeria,” BMC Infectious Diseases, vol. 5, no. 1, p. 110, 2005.
View at: Publisher Site | Google Scholar
E. M. R. Shehab El-Din, M. M. A. El-Sokkary, M. R. Bassiouny, and R. Hassan, “Epidemiology of neonatal sepsis and implicated pathogens: a study from Egypt,” BioMed Research International, vol. 2015, Article ID 509484, 11 pages, 2015.
View at: Publisher Site | Google Scholar
M. Berhane, N. W. Gidi, B. Eshetu et al., “Clinical profile of neonates admitted with sepsis to neonatal intensive care unit of Jimma medical center, a tertiary Hospital in Ethiopia,” Ethiopian Journal of Health Sciences, vol. 31, no. 3, pp. 485–494, 2021.
View at: Publisher Site | Google Scholar
M. J. Bizzarro, C. Raskind, R. S. Baltimore, and P. G. Gallagher, “Seventy-five years of neonatal sepsis at Yale: 1928-2003,” Pediatrics, vol. 116, no. 3, pp. 595–602, 2005.
View at: Publisher Site | Google Scholar
A. L. Shane and B. J. Stoll, “Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis,” American Journal of Perinatology, vol. 30, no. 2, pp. 131–141, 2013.
View at: Publisher Site | Google Scholar
R. U. Varsha, M. Sikka, M. M. A. Faridi, and N. Madan, “Validity of hematologic parameters in identification of early and late onset neonatal infection,” Indian Journal of Pathology & Microbiology, vol. 46, no. 4, pp. 565–568, 2003.
View at: Google Scholar
A. Al-Taiar, M. S. Hammoud, L. Cuiqing et al., “Neonatal infections in China, Malaysia, Hong Kong and Thailand,” Archives of Disease in Childhood - Fetal and Neonatal Edition, vol. 98, no. 3, pp. F249–F255, 2013.
View at: Publisher Site | Google Scholar
R. Tiskumara, S. H. Fakharee, C. Q. Liu et al., “Neonatal infections in Asia,” Archives of Disease in Childhood - Fetal and Neonatal Edition, vol. 94, no. 2, pp. F144–F148, 2009.
View at: Publisher Site | Google Scholar
H. Afroz, M. Fakruddin, M. A. Hakim, and J. D. Sharma, “Neonatal bacteremia in a neonatal intensive care unit: analysis of causative organisms and antimicrobial susceptibility,” Bangladesh Journal of Medical Science, vol. 10, pp. 187–194, 2011.
View at: Google Scholar
R. Viswanathan, A. K. Singh, S. Mukherjee, R. Mukherjee, P. Das, and S. Basu, “Aetiology and antimicrobial resistance of neonatal sepsis at a tertiary Care Centre in Eastern India: a 3 year study,” The Indian Journal of Pediatrics, vol. 78, no. 4, pp. 409–412, 2011.
View at: Publisher Site | Google Scholar
S. Chaurasia, S. Sivanandan, R. Agarwal, S. Ellis, M. Sharland, and M. J. Sankar, “Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance,” BMJ, vol. 364, article k5314, 2019.
View at: Publisher Site | Google Scholar
N. S. Yadav, S. Sharma, D. K. Chaudhary et al., “Bacteriological profile of neonatal sepsis and antibiotic susceptibility pattern of isolates admitted at Kanti Children’s hospital, Kathmandu, Nepal,” BMC Research Notes, vol. 11, no. 1, p. 301, 2018.
View at: Publisher Site | Google Scholar
B. R. Raghubanshi, K. D. Sagili, W. W. Han et al., “Antimicrobial resistance among neonates with bacterial sepsis and their clinical outcomes in a tertiary hospital in Kathmandu valley, Nepal,” Tropical Medicine and Infectious Disease, vol. 6, no. 2, p. 56, 2021.
View at: Publisher Site | Google Scholar
D. Sharma, N. Farahbakhsh, S. Shastri, and P. Sharma, “Biomarkers for diagnosis of neonatal sepsis: a literature review,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 31, no. 12, pp. 1646–1659, 2018.
View at: Publisher Site | Google Scholar
K. Murphy and J. Weiner, “Use of leukocyte counts in evaluation of early-onset neonatal sepsis,” The Pediatric Infectious Disease Journal, vol. 31, no. 1, pp. 16–19, 2012.
View at: Publisher Site | Google Scholar
H. J. Rozycki, G. E. Stahl, and S. Baumgart, “Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis,” The Pediatric Infectious Disease Journal, vol. 6, pp. 440–442, 1987.
View at: Publisher Site | Google Scholar
R. D. Christensen, G. Rothstein, H. R. Hill, and R. T. Hall, “Fatal early onset group B streptococcal sepsis with normal leukocyte counts,” Pediatric Infectious Disease, vol. 4, no. 3, pp. 242–244, 1985.
View at: Publisher Site | Google Scholar
C. P. Hornik, D. K. Benjamin, K. C. Becker et al., “Use of the complete blood cell count in early-onset neonatal sepsis,” Pediatric Infectious Disease Journal, vol. 31, no. 8, pp. 799–802, 2012.
View at: Publisher Site | Google Scholar
T. B. Newman, K. M. Puopolo, S. Wi, D. Draper, and G. J. Escobar, “Interpreting complete blood counts soon after birth in newborns at risk for sepsis,” Pediatrics, vol. 126, no. 5, pp. 903–909, 2010.
View at: Publisher Site | Google Scholar
J. S. Gerdes, “Clinicopathologic Approach to the Diagnosis of Neonatal Sepsis,” Clinics in Perinatology, vol. 18, no. 2, pp. 361–381, 1991.
View at: Publisher Site | Google Scholar
D. O’Reilly, C. A. Murphy, R. Drew et al., “Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade,” Pediatric Research, vol. 91, no. 2, pp. 359–367, 2022.
View at: Publisher Site | Google Scholar
J. Wang, Z. Wang, M. Zhang, Z. Lou, J. Deng, and Q. Li, “Diagnostic value of mean platelet volume for neonatal sepsis: a systematic review and meta-analysis,” Medicine, vol. 99, no. 32, article e21649, 2020.
View at: Publisher Site | Google Scholar
S. B. Hanaganahalli, S. Sreeram, M. Bompada, S. K. Kuppannagari, P. K. Suresh, and C. S. Philipose, “Is MPV a predictive marker for neonatal sepsis? A pilot study,” Journal of Pediatric Hematology/Oncology, vol. 40, no. 7, pp. 548–552, 2018.
View at: Publisher Site | Google Scholar
S. Timilsina, S. Karki, A. Gautam, P. Bhusal, G. Paudel, and D. Sharma, “Correlation between maternal and umbilical cord blood in pregnant women of Pokhara Valley: a cross sectional study,” BMC Pregnancy Childbirth, vol. 18, no. 1, p. 70, 2018.
View at: Publisher Site | Google Scholar
F. Catal, C. Tayman, A. Tonbul et al., “Mean platelet volume (MPV) may simply predict the severity of sepsis in preterm infants,” Clinical Laboratory, vol. 60, pp. 1193–1200, 2014.
View at: Publisher Site | Google Scholar
J. M. Al-Marzoki, Z. W. Al-Maaroof, and A. H. Kadhum, “Determination of reference ranges for full blood count parameters in neonatal cord plasma in Hilla, Babil, Iraq,” Journal of Blood Medicine, vol. 3, pp. 113–118, 2012.
View at: Publisher Site | Google Scholar
R. M. Bateman, M. D. Sharpe, M. Singer, and C. G. Ellis, “The effect of sepsis on the erythrocyte,” International Journal of Molecular Sciences, vol. 18, no. 9, p. 1932, 2017.
View at: Publisher Site | Google Scholar
Z. Hu, G. Lippi, and M. Montagnana, “Diagnostic and prognostic value of red blood cell distribution width in sepsis: a narrative review,” Clinical Biochemistry, vol. 77, pp. 1–6, 2020.
View at: Publisher Site | Google Scholar
F. S. Biteker, B. Özlek, E. Özlek, C. Çil, and O. Çelik, “Red blood cell distribution width in sepsis,” The American Journal of Emergency Medicine, vol. 36, pp. 1695-1696, 2018.
View at: Publisher Site | Google Scholar
J. Chen, L. Jin, and T. Yang, “Clinical study of RDW and prognosis in sepsis new borns,” Biomedical Research, vol. 25, no. 4, pp. 576–579, 2014.
View at: Google Scholar
S. Golhar, A. Madhura, U. Chauhan, and A. Nayak, “Utility of red cell distribution width (RDW) in diagnosis and prognosis of early-onset neonatal sepsis in term neonates,” SciMedicine Journal, vol. 3, no. 3, pp. 257–264, 2021.
View at: Publisher Site | Google Scholar
B. F. Guo and S. Z. Sun, “Diagnostic accuracy of a dynamically increased red blood cell distribution width in very low birth weight infants with serious bacterial infection,” Italian Journal of Pediatrics, vol. 47, no. 1, article 44, 2021.
View at: Publisher Site | Google Scholar
O. Bulut, A. Akcakaya, N. Bulut, and F. Ovali, “Elevated red cell distribution width as a useful marker in neonatal sepsis,” Journal of Pediatric Hematology/Oncology, vol. 43, no. 5, pp. 180–185, 2021.
View at: Publisher Site | Google Scholar
M. S. Ahmad and A. Waheed, “Platelet counts, MPV and PDW in culture proven and probable neonatal sepsis and association of platelet counts with mortality rate,” Journal of the College of Physicians and Surgeons–Pakistan, vol. 24, no. 5, pp. 340–344, 2014.
View at: Google Scholar
A. Majumdar, S. Biswas, and A. Jana, “Platelet indices as an earlier and economical marker of neonatal sepsis,” Iraqi Journal of Hematology, vol. 10, no. 2, p. 108, 2021.
View at: Publisher Site | Google Scholar
C. H. Patrick and J. Lazarchick, “The effect of bacteremia on automated platelet measurements in neonates,” American Journal of Clinical Pathology, vol. 93, no. 3, pp. 391–394, 1990.
View at: Publisher Site | Google Scholar
S. Mishra, S. Jaiswar, S. Saad et al., “Platelet indices as a predictive marker in neonatal sepsis and respiratory distress in preterm prelabor rupture of membranes,” International Journal of Hematology, vol. 113, no. 2, pp. 199–206, 2021.
View at: Publisher Site | Google Scholar
B. Dundar, B. Dincgez Cakmak, G. Ozgen, F. N. Tasgoz, T. Guclu, and G. Ocakoglu, “Platelet indices in preterm premature rupture of membranes and their relation with adverse neonatal outcomes,” The Journal of Obstetrics and Gynaecology Research, vol. 44, no. 1, pp. 67–73, 2018.
View at: Publisher Site | Google Scholar
G. K. Bunduki and Y. Adu-Sarkodie, “The usefulness of C-reactive protein as a biomarker in predicting neonatal sepsis in a sub-Saharan African region,” BMC Research Notes, vol. 13, no. 1, 2020.
View at: Publisher Site | Google Scholar
B. A. West, O. Peterside, R. O. Ugwu, and A. U. Eneh, “Prospective evaluation of the usefulness of C-reactive protein in the diagnosis of neonatal sepsis in a sub-Saharan African region,” Antimicrobial Resistance and Infection Control, vol. 1, no. 1, p. 22, 2012.
View at: Publisher Site | Google Scholar
N. Hofer, E. Zacharias, W. Muller, and B. Resch, “An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks,” Neonatology, vol. 102, no. 1, pp. 25–36, 2012.
View at: Publisher Site | Google Scholar
A. M. S. Tosson, D. Koptan, R. Abdel Aal, and E. M. Abd, “Evaluation of serum and salivary C-reactive protein for diagnosis of late-onset neonatal sepsis: a single center cross-sectional study,” Jornal de Pediatria, vol. 97, no. 6, pp. 623–628, 2021.
View at: Publisher Site | Google Scholar
B. A. Shah and J. F. Padbury, “Neonatal sepsis: an old problem with new insights,” Virulence, vol. 5, no. 1, pp. 170–178, 2014.
View at: Publisher Site | Google Scholar
M. Mussap, “Laboratory medicine in neonatal sepsis and inflammation,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, Supplement 4, pp. 24–26, 2012.
View at: Publisher Site | Google Scholar
S. M. Walliullah, M. N. Islam, M. Siddika, M. A. Hossain, and A. K. Chowdhury, “Role of micro-ESR and I/T ratio in the early diagnosis of neonatal sepsis,” Mymensingh Medical Journal, vol. 18, no. 1, pp. 56–61, 2009.
View at: Google Scholar
R. Kafle, J. Yadav, B. K. Gupta, and B. K. Gupta, “Role of micro ESR in the evaluation of neonatal sepsis,” Journal of Universal College of Medical Sciences, vol. 7, no. 2, pp. 25–29, 2020.
View at: Publisher Site | Google Scholar
S. R. Manandhar and R. Basnet, “Micro-erythrocyte sedimentation rate in neonatal sepsis of a tertiary hospital: a descriptive cross-sectional study,” Journal of Nepal Medical Association, vol. 58, no. 226, pp. 377–382, 2020.
View at: Publisher Site | Google Scholar
A. Z. Ghaliyah, A. S. Prabhu, and K. S. Sahana, “Role of micro- ESR in the evaluation of suspected sepsis in neonates,” International Journal of Sciences and Research., vol. 4, no. 8, pp. 311–314, 2015.
View at: Google Scholar

Copyright

Copyright © 2022 Priyatam Khadka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

625

Downloads

563

Citations